يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"PI3K alpha"', وقت الاستعلام: 0.71s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
  5. 5
    دورية أكاديمية

    المساهمون: M. Mounayar, E. Kefaloyianni, B. Smith, Z. Solhjou, O.H. Maarouf, J. Azzi, L. Chabtini, P. Fiorina, M. Krau, R. Briddell, W. Fodor, A. Herrlich, R. Abdi

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25753288; info:eu-repo/semantics/altIdentifier/wos/WOS:000354882500018; volume:33; issue:6; firstpage:1892; lastpage:1901; numberofpages:10; journal:STEM CELLS; http://hdl.handle.net/2434/499134Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84929791799

  6. 6

    المساهمون: Institut Català de la Salut, [Ros S, Wright AJ, D'Santos P, Hu DE, Hesketh RL, Lubling Y] Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. Cancer Research UK Cambridge Cancer Centre, Cambridge, UK. [Oliveira M] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia
    Cancer Cell

    مصطلحات موضوعية: 0301 basic medicine, Cancer Research, PI3K alpha inhibition, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], Estrogen receptor, Medicaments antineoplàstics - Ús terapèutic, Mice, SCID, chemistry.chemical_compound, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, Mama - Càncer, Mice, Inbred NOD, Antineoplastic Combined Chemotherapy Protocols, Medicine, Other subheadings::/therapeutic use [Other subheadings], FDG-PET, Fulvestrant, Mice, Knockout, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], medicine.diagnostic_test, Imidazoles, Glucose analog, Magnetic Resonance Imaging, hexokinase 2, Oncology, Receptors, Estrogen, Positron emission tomography, 030220 oncology & carcinogenesis, MCF-7 Cells, Biomarker (medicine), biomarker, Female, medicine.drug, MRI, Class I Phosphatidylinositol 3-Kinases, Breast Neoplasms, Article, 03 medical and health sciences, Breast cancer, breast cancer, Lactate dehydrogenase, Cell Line, Tumor, Animals, Humans, Lactic Acid, terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], hyperpolarized [1-(13)C]pyruvate, Protein Kinase Inhibitors, Fluorodeoxyglucose, Oncogene, business.industry, Otros calificadores::/uso terapéutico [Otros calificadores], hyperpolarized [1-13C]pyruvate, Forkhead Box Protein M1, FOXM1, treatment response, lactate dehydrogenase, Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, Xenograft Model Antitumor Assays, Oxazepines, Tamoxifen, 030104 developmental biology, chemistry, Drug Resistance, Neoplasm, Cancer research, business

    وصف الملف: application/pdf

  7. 7
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية